|Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing|
I Vanden Bempt, P Van Loo, M Drijkoningen, P Neven, A Smeets, ...
Journal of clinical oncology 26 (30), 4869-4874, 2008
|The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor−/progesterone receptor−/HER-2− breast carcinomas|
L Verlinden, IV Bempt, G Eelen, M Drijkoningen, I Verlinden, K Marchal, ...
Cancer research 67 (14), 6574-6581, 2007
|Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive|
B Van Calster, IV Bempt, M Drijkoningen, N Pochet, J Cheng, ...
Breast cancer research and treatment 113 (1), 181-187, 2009
|Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis|
V Van Belle, B Van Calster, O Brouckaert, I Vanden Bempt, S Pintens, ...
J Clin Oncol 28 (27), 4129-4134, 2010
|The complexity of genotypic alterations underlying HER2-positive breast cancer: an explanation for its clinical heterogeneity|
IV Bempt, M Drijkoningen, C De Wolf-Peeters
Current opinion in oncology 19 (6), 552-557, 2007
|Real‐time reverse transcription‐PCR and fluorescence in‐situ hybridization are complementary to understand the mechanisms involved in HER‐2/neu overexpression in human breast …|
I Vanden Bempt, V Vanhentenrijk, M Drijkoningen, I Wlodarska, ...
Histopathology 46 (4), 431-441, 2005
|T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response|
P Van Loo, T Tousseyn, V Vanhentenrijk, D Dierickx, A Malecka, IV Bempt, ...
Haematologica 95 (3), 440-448, 2010
|Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1|
S Pintens, P Neven, M Drijkoningen, V Van Belle, P Moerman, ...
Journal of clinical pathology 62 (7), 624-628, 2009
|Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs|
A Smeets, A Daemen, IV Bempt, O Gevaert, B Claes, H Wildiers, ...
Breast cancer research and treatment 129 (3), 767-776, 2011
|BRAF mutation testing with a rapid, fully integrated molecular diagnostics system|
F Janku, B Claes, HJ Huang, GS Falchook, B Devogelaere, M Kockx, ...
Oncotarget 6 (29), 26886, 2015
|Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response|
C Boeckx, C Weyn, IV Bempt, V Deschoolmeester, A Wouters, ...
BMC Research Notes 7 (1), 337, 2014
|Actinobaculum schaalii causing Fournier's gangrene|
IV Bempt, S Van Trappen, I Cleenwerck, P De Vos, K Camps, A Celens, ...
Journal of clinical microbiology 49 (6), 2369-2371, 2011
|Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy|
G Eelen, IV Bempt, L Verlinden, M Drijkoningen, A Smeets, P Neven, ...
Oncogene 27 (30), 4233-4241, 2008
|Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP 142) reveal similar immune cell staining patterns in melanoma when using the same sensitive …|
KA Schats, EA Van Vré, S De Schepper, C Boeckx, DM Schrijvers, ...
Histopathology 70 (2), 253-263, 2017
|Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors|
O Brouckaert, S Pintens, V Van Belle, S Van Huffel, E Camerlynck, ...
Breast cancer research and treatment 115 (2), 349-358, 2009
|Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer|
P Neven, B Van Calster, I Van den Bempt, S Van Huffel, V Van Belle, ...
Breast cancer research and treatment 110 (1), 153-159, 2008
|Relationship between classic Hodgkin lymphoma and overlapping large cell lymphoma investigated by comparative expressed sequence hybridization expression profiling|
V Vanhentenrijk, I Vanden Bempt, D Dierickx, G Verhoef, I Wlodarska, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006
|Body mass index and HER-2 overexpression in breast cancer patients over 50 years of age|
T Van Mieghem, K Leunen, N Pochet, B De Moor, F De Smet, F Amant, ...
Breast cancer research and treatment 106 (1), 127-133, 2007
|Limited Clinical Benefit from Trastuzumab in Recurrent Endometrial Cancer|
I Vandenput, IV Bempt, K Leunen, P Neven, P Berteloot, P Moerman, ...
Gynecologic and obstetric investigation 67 (1), 46-48, 2009
|Clinicopathological features of inflammatory versus noninflammatory locally advanced nonmetastatic breast cancer|
B Brouwers, R Paridaens, JP Lobelle, W Hendrickx, A Smeets, P Neven, ...
Tumor Biology 29 (4), 211-216, 2008